112 related articles for article (PubMed ID: 32202735)
1. [Expression of plasma microRNA in patients with acromegaly].
Lutsenko AS; Belaya ZE; Przhiyalkovskaya EG; Nikitin AG; Koshkin PA; Lapshina AM; Khandaeva PM; Melnichenko GA
Probl Endokrinol (Mosk); 2019 Nov; 65(5):311-318. PubMed ID: 32202735
[TBL] [Abstract][Full Text] [Related]
2. Circulating Plasma MicroRNA in Patients With Active Acromegaly.
Lutsenko A; Belaya Z; Nikitin A; Solodovnikov A; Lapshina A; Koshkin P; Vorontsova M; Rozhinskaya L; Melnichenko G; Dedov I
J Clin Endocrinol Metab; 2022 Jan; 107(2):500-511. PubMed ID: 34550352
[TBL] [Abstract][Full Text] [Related]
3. [Plasma miRNA expression in patients with genetically confirmed multiple endocrine neoplasia type 1 syndrome and its phenocopies].
Trukhina DA; Mamedova EO; Nikitin AG; Koshkin PA; Belaya ZE; Melnichenko GA
Probl Endokrinol (Mosk); 2024 Jan; 69(6):70-85. PubMed ID: 38311997
[TBL] [Abstract][Full Text] [Related]
4. Effects of active acromegaly on bone mRNA and microRNA expression patterns.
Belaya Z; Grebennikova T; Melnichenko G; Nikitin A; Solodovnikov A; Brovkina O; Grigoriev A; Rozhinskaya L; Lutsenko A; Dedov I
Eur J Endocrinol; 2018 Apr; 178(4):353-364. PubMed ID: 29374071
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-29c-3p is downregulated in patients with acromegaly.
Korkmaz H; Hekimler Öztürk K; Torus B
Turk J Med Sci; 2021 Aug; 51(4):2081-2086. PubMed ID: 34013701
[TBL] [Abstract][Full Text] [Related]
6. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
7. miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly.
Henriques DG; Miranda RL; Dezonne RS; Wildemberg LE; Camacho AHDS; Chimelli L; Kasuki L; Lamback EB; Guterres A; Gadelha MR
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769196
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
9. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
10. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA dysregulation in manic and euthymic patients with bipolar disorder.
Camkurt MA; Karababa İF; Erdal ME; Kandemir SB; Fries GR; Bayazıt H; Ay ME; Kandemir H; Ay ÖI; Coşkun S; Çiçek E; Selek S
J Affect Disord; 2020 Jan; 261():84-90. PubMed ID: 31605836
[TBL] [Abstract][Full Text] [Related]
12. High Throughput qPCR Expression Profiling of Circulating MicroRNAs Reveals Minimal Sex- and Sample Timing-Related Variation in Plasma of Healthy Volunteers.
Mooney C; Raoof R; El-Naggar H; Sanz-Rodriguez A; Jimenez-Mateos EM; Henshall DC
PLoS One; 2015; 10(12):e0145316. PubMed ID: 26699132
[TBL] [Abstract][Full Text] [Related]
13. Circulating Plasma microRNA to Differentiate Cushing's Disease From Ectopic ACTH Syndrome.
Belaya Z; Khandaeva P; Nonn L; Nikitin A; Solodovnikov A; Sitkin I; Grigoriev A; Pikunov M; Lapshina A; Rozhinskaya L; Melnichenko G; Dedov I
Front Endocrinol (Lausanne); 2020; 11():331. PubMed ID: 32582027
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease.
Divi SN; Markova DZ; Fang T; Guzek R; Kurd MF; Rihn JA; Hilibrand AS; Anderson DG; Vaccaro AR; Schroeder GD; Kepler CK
Spine (Phila Pa 1976); 2020 May; 45(9):E499-E507. PubMed ID: 31770330
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
[TBL] [Abstract][Full Text] [Related]
16. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated microRNA expression in rheumatoid arthritis families-a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls.
Renman E; Brink M; Ärlestig L; Rantapää-Dahlqvist S; Lejon K
Clin Rheumatol; 2021 Jun; 40(6):2387-2394. PubMed ID: 33210166
[TBL] [Abstract][Full Text] [Related]
18. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study.
Kacperska MJ; Jastrzebski K; Tomasik B; Walenczak J; Konarska-Krol M; Glabinski A
J Mol Neurosci; 2015 May; 56(1):154-63. PubMed ID: 25487315
[TBL] [Abstract][Full Text] [Related]
19. Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsy.
Raoof R; Bauer S; El Naggar H; Connolly NMC; Brennan GP; Brindley E; Hill T; McArdle H; Spain E; Forster RJ; Prehn JHM; Hamer H; Delanty N; Rosenow F; Mooney C; Henshall DC
EBioMedicine; 2018 Dec; 38():127-141. PubMed ID: 30396857
[TBL] [Abstract][Full Text] [Related]
20. Differential microRNA Profile in Operational Tolerance: A Potential Role in Favoring Cell Survival.
Cabral A; da Silva Cândido D; Monteiro SM; Lemos F; Saitovitch D; Noronha IL; Alves LF; Geraldo MV; Kalil J; Cunha-Neto E; Pinto Ferreira LR; Coelho V
Front Immunol; 2019; 10():740. PubMed ID: 31073299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
